Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Exchange Rate Effect came in at -$130000.0 in Q1 2026, down 103.12% year-on-year from $4.2 million in Q1 2025, and down 25.0% on a QoQ basis from -$104000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Exchange Rate Effect data on file, last reported at -$130000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 103.12% year-over-year to -$130000.0 in Q1 2026; TTM through Mar 2026 was $392000.0, a 128.63% increase from a year earlier, with the FY2025 full-year figure at $458000.0, up 127.39% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$130000.0, down from -$104000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for XENE reached as high as $814000.0 in Q4 2022 and fell as low as -$2.7 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$203058.8 across 5 years, with a median of -$64000.0 in 2025.
- Across the five-year window, Exchange Rate Effect jumped 1079.71% in 2022 and plunged 722.03% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at $814000.0 in 2022, then sank by 69.78% to $246000.0 in 2023, then tumbled by 570.33% to -$1.2 million in 2024, then surged by 91.01% to -$104000.0 in 2025, then slipped by 25.0% to -$130000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$130000.0 in Q1 2026, -$104000.0 in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | 54,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -367,000.00 |
| Mar 31, 2024 | -367,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Dec 31, 2023 | 246,000.00 |